Holen Sie sich die Stockscreener-App
1.59
3.64%
-0.06
Vorhandelsmarkt:
1.58
-0.01
-0.63%
Schlusskurs vom Vortag:
$1.65
Offen:
$1.6
24-Stunden-Volumen:
20.63M
Relative Volume:
1.41
Marktkapitalisierung:
$1.05B
Einnahmen:
$29.48M
Nettoeinkommen (Verlust:
$-201.19M
KGV:
-4.9688
EPS:
-0.32
Netto-Cashflow:
$-216.50M
1W Leistung:
-9.14%
1M Leistung:
-9.66%
6M Leistung:
-64.98%
1J Leistung:
-51.82%
1-Tages-Spanne:
$1.53
$1.63
1-Wochen-Bereich:
$1.53
$1.7591
52-Wochen-Spanne:
$1.4601
$5.34
Geron Corp Stock (GERN) Company Profile
Firmenname
Geron Corp
Sektor
Branche
Telefon
(650) 473-7700
Adresse
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA
Vergleichen Sie GERN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GERN
Geron Corp
|
1.59 | 1.05B | 29.48M | -201.19M | -216.50M | -0.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.82 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.23 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
591.87 | 36.10B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
270.02 | 35.03B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
272.17 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Geron Corp Stock (GERN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-27 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2025-02-26 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-11-05 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-09-09 | Eingeleitet | Leerink Partners | Outperform |
| 2024-04-30 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-04-29 | Eingeleitet | TD Cowen | Buy |
| 2024-03-15 | Bestätigt | Needham | Buy |
| 2023-09-12 | Hochstufung | Goldman | Neutral → Buy |
| 2023-03-28 | Eingeleitet | Goldman | Neutral |
| 2022-10-28 | Eingeleitet | Wedbush | Outperform |
| 2022-07-28 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-11-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-02-18 | Fortgesetzt | B. Riley Securities | Buy |
| 2020-08-03 | Eingeleitet | Stifel | Buy |
| 2019-11-19 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-09-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-08-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-04-09 | Hochstufung | Needham | Hold → Buy |
| 2019-01-31 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2018-10-02 | Herabstufung | B. Riley FBR | Buy → Neutral |
| 2018-07-05 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2016-09-13 | Bestätigt | FBR & Co. | Outperform |
| 2016-09-13 | Bestätigt | FBR Capital | Outperform |
| 2015-12-07 | Bestätigt | Piper Jaffray | Overweight |
| 2015-04-21 | Eingeleitet | Oppenheimer | Outperform |
| 2014-06-12 | Hochstufung | MLV & Co | Hold → Buy |
| 2014-03-12 | Herabstufung | MLV & Co | Buy → Hold |
| 2013-12-10 | Bestätigt | MLV & Co | Buy |
| 2013-12-10 | Hochstufung | Needham | Hold → Buy |
| 2013-11-08 | Bestätigt | MLV & Co | Buy |
| 2013-10-16 | Eingeleitet | MLV & Co | Buy |
| 2012-08-30 | Eingeleitet | Stifel Nicolaus | Buy |
| 2012-06-28 | Eingeleitet | Needham | Hold |
Alle ansehen
Geron Corp Aktie (GERN) Neueste Nachrichten
GERN INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
GERN INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - GlobeNewswire Inc.
Geron Corp.: A Compelling Potential Buying Opportunity Thanks To Bearish Comments (GERN) - Seeking Alpha
Geron Q1 2025 Earnings: Complete Coverage of May 7 Financial Results and Conference Call - Stock Titan
Geron Plans to Announce First Quarter 2025 Financial Results on May 7, 2025 - Yahoo Finance
Geron Corporation's (NASDAQ:GERN) Profit Outlook - simplywall.st
GERN Securities Lawsuit Filed Against Geron Corporation- Contact the DJS Law Group to Discuss Your Rights - PR Newswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Geron - The Malaysian Reserve
GERN INVESTOR ALERT: Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
When Can We Expect A Profit From Geron Corporation (NASDAQ:GERN)? - Yahoo Finance
GERN Investors Have Opportunity to Lead Geron Corporation Securities Fraud Lawsuit - MarketScreener
GERN Investors Have Opportunity to Lead Geron Corporation Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
GERN Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Geron Corporation (GERN)Contact Kessler Topaz Meltzer & Check, LLP - Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against XPLR, Geron, enCore, and TFI and Encourages Investors to Contact the Firm - TradingView
Deep Track Capital, LP's Strategic Acquisition of Geron Corp Shares - GuruFocus
Is Geron Corporation (NASDAQ:GERN) The Top Penny Stock That Will Skyrocket? - Insider Monkey
Top 10 Penny Stocks That Will Skyrocket - Insider Monkey
GERN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
Class Action Filed Against Geron Corporation (GERN) Seeking Recovery for InvestorsContact The Gross Law Firm - PR Newswire
GERN INVESTOR NOTICE: Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Eastern Progress
GERN INVESTOR NOTICE: Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
Indo-Asian News Service - IANS India Pvt Ltd
Faruqi & Faruqi Reminds Geron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 12, 2025GERN - PR Newswire
Geron Corporation Sued for Securities Law ViolationsContact Levi & Korsinsky Before May 12, 2025 to Discuss Your RightsGERN - PR Newswire
Geron reports inducement grants under Nasdaq listing rule 5635(C)(4) -March 19, 2025 at 04:43 pm EDT - Marketscreener.com
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Is Geron (GERN) Among the Most Oversold Penny Stocks to Buy According to Analysts? - Insider Monkey
Geron Corp: How Concerned Should We Be About Rytelo Sales? (NASDAQ:GERN) - Seeking Alpha
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Geron - Markets Insider
10 Most Oversold Penny Stocks to Buy According to Analysts - Insider Monkey
Rosen Law Firm Urges Geron Corporation (NASDAQ: GERN) Stockholders to Contact the Firm for Information About Their Rights - Business Wire
GERN ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Geron Corporation Investors - TradingView
GERN INVESTOR ALERT: Geron Corporation Investors with Substantia - GuruFocus.com
GERN INVESTOR ALERT: Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - The Malaysian Reserve
GERN INVESTOR ALERT: Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
HC Wainwright Reiterates Neutral Rating for Geron (NASDAQ:GERN) - Defense World
GERN INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
Investor Brings Securities Class Action Against Geron Corp. (1) - Bloomberg Tax
SBI Securities Co. Ltd. Acquires New Holdings in Geron Co. (NASDAQ:GERN) - Defense World
Geron’s SWOT analysis: biotech stock faces pivotal year for growth By Investing.com - Investing.com South Africa
Geron Corp appoints interim CEO amid leadership shuffle By Investing.com - Investing.com Australia
Geron Corp reveals CEO is leaving - The Pharma Letter
H.C. Wainwright holds neutral on Geron stock post-EU approval - Investing.com
H.C. Wainwright holds neutral on Geron stock post-EU approval By Investing.com - Investing.com South Africa
Geron’s SWOT analysis: biotech stock faces pivotal year for growth - Investing.com
Geron Co. (NASDAQ:GERN) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Longtime Bay Area biotech CEO abruptly steps down - The Business Journals
Geron Announces Leadership Change with New Interim CEO - TipRanks
Geron Corp appoints interim CEO amid leadership shuffle - Investing.com India
Geron’s RYTELO gains EC approval for certain blood cancers - Investing.com
Finanzdaten der Geron Corp-Aktie (GERN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.05%
1.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):